Topic Hub
52 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 52 of 52 clinical reviews.
A clinical comparison of Adderall (mixed amphetamine salts) and Vyvanse (lisdexamfetamine) covering mechanism, dosing, duration, abuse potential, side effects, and how each fits into current ADHD treatment guidelines.
Read clinical reviewA clinician-reviewed guide to adult ADHD covering DSM-5 diagnostic criteria, FDA-approved medications, non-stimulant options, comorbidities like brain fog and narcolepsy, and the latest evidence from named trials and guidelines.
Read clinical reviewA comprehensive, clinician-reviewed guide to ADHD in children covering DSM-5 diagnostic criteria, stimulant and non-stimulant medications, behavioral therapies, and how ADHD symptoms differ from normal development or other conditions like brain fog and narcolepsy.
Read clinical reviewA physician-reviewed guide to ADHD stimulant titration covering methylphenidate and amphetamine dose escalation schedules, switching protocols, modafinil dosing, and how to recognize an optimal dose.
Read clinical reviewA physician-reviewed guide to amphetamine/dextroamphetamine (Adderall, Adderall XR, Mydayis) covering mechanism, dosing, side effects, comparisons with Vyvanse, Ritalin, modafinil, and armodafinil, and how to choose the right stimulant for ADHD or narcolepsy.
Read clinical reviewA clinician-reviewed guide to armodafinil (Nuvigil): FDA-approved uses, dosing schedules, side effects, mechanism of action, and head-to-head comparisons with modafinil, methylphenidate, and amphetamines.
Read clinical reviewEverything clinicians and patients need to know about atomoxetine (Strattera): mechanism, dosing, onset, side effects, comparisons with stimulants, and who benefits most from a non-stimulant approach.
Read clinical reviewA clinician-reviewed guide to the best supplements for brain fog, covering omega-3s, B vitamins, magnesium, lion's mane, citicoline, and when to consider prescription options instead.
Read clinical reviewA clinically reviewed guide to brain fog covering its most common causes (hormonal changes, sleep disorders, ADHD, metabolic dysfunction), what the research shows, and which interventions actually move the needle on cognition.
Read clinical reviewA comprehensive clinical overview of bromantane, covering its mechanism of action, cognitive and physical effects, safety profile, and direct comparisons with modafinil, armodafinil, methylphenidate, and amphetamine-based stimulants.
Read clinical reviewYes, adults can and do receive ADHD diagnoses. Learn how adult ADHD is evaluated, which medications are FDA-approved, how stimulants compare to non-stimulants, and what the evidence says about nootropics as adjuncts.
Read clinical reviewChemobrain (cancer-related cognitive impairment) affects up to 75% of cancer survivors. Learn the mechanisms, risk factors, evidence-based treatments, and when to seek specialist care.
Read clinical reviewA physician-reviewed guide covering cognitive function, ADHD, hormonal influences on brain performance, and evidence-based interventions for adults at every life stage.
Read clinical reviewA clinician-reviewed guide to cognitive development, ADHD diagnosis, stimulant and non-stimulant medications, nutrition, sleep, and exercise as they affect mental performance in children aged 6, 17.
Read clinical reviewA physician-reviewed guide to cognitive aging, ADHD, hormonal influences, and evidence-based interventions for mental performance in older adults, postmenopausal women, and across the lifespan.
Read clinical reviewHow estrogen loss after menopause affects memory, focus, and executive function, and what the clinical evidence says about HRT, lifestyle, and ADHD medication adjustments for postmenopausal women.
Read clinical reviewA physician-reviewed guide to the neuroscience, tested interventions, and real clinical data behind improving cognitive function, memory, processing speed, and mental performance in adults.
Read clinical reviewA clinician-reviewed guide to cognitive decline covering brain fog, ADHD in adults and children, narcolepsy, perimenopause, and evidence-based interventions with primary-source citations.
Read clinical reviewA clinician-reviewed guide covering ADHD treatment in adults and children, estrogen-dopamine interactions in postmenopausal women, medication safety in pregnancy, and evidence-based strategies to protect cognitive performance in knowledge workers.
Read clinical reviewA complete 2026 price guide for Adderall (amphetamine salts), covering brand vs. generic costs, insurance tiers, prior authorization, GoodRx savings, modafinil comparisons, and telehealth options for ADHD treatment.
Read clinical reviewA detailed breakdown of modafinil costs in 2026, including brand vs. generic pricing, insurance coverage rules, prior authorization tips, and how it compares to Adderall and other stimulants.
Read clinical reviewA physician-reviewed breakdown of nootropics, prescription cognitive enhancers, and the real clinical evidence behind popular brain-boosting compounds including modafinil, racetams, and natural supplements.
Read clinical reviewAdderall can cause or worsen anxiety in some patients. Learn who is most at risk, what the mechanism is, how doses and timing matter, and what alternatives exist for ADHD with comorbid anxiety.
Read clinical reviewCold plunge and cognition: a clinician-reviewed breakdown of the norepinephrine response, relevant human trials, and how cold-water immersion compares to stimulant medications for focus and mental clarity.
Read clinical reviewA physician-reviewed guide to donepezil (Aricept) and how it compares with modafinil, armodafinil, methylphenidate (Ritalin/Concerta), and amphetamines (Adderall) for cognitive performance, memory, and mental clarity.
Read clinical reviewA clinical comparison of donepezil and memantine for Alzheimer's disease and other dementias, covering mechanisms, dosing, trial data, side effects, and combination therapy evidence.
Read clinical reviewA clinician-reviewed guide to executive function deficits covering ADHD in adults and children, narcolepsy-related cognitive impairment, cognitive decline, and evidence-based treatments including stimulants, behavioral therapy, and hormonal considerations.
Read clinical reviewA clinician-reviewed guide to guanfacine (Intuniv) covering mechanism, dosing, side effects, and how it stacks up against Adderall, Ritalin, modafinil, and armodafinil for ADHD and cognitive performance.
Read clinical reviewVyvanse typically begins working 1.5 to 2 hours after a dose, peaks at 3 to 4 hours, and lasts up to 14 hours. Learn the full pharmacokinetic timeline, what affects onset speed, and how Vyvanse compares to Adderall, modafinil, and nootropics.
Read clinical reviewA clinician-reviewed guide to insurance coverage for ADHD stimulants like Adderall and Vyvanse, prior authorization steps, 2026 cash prices, and alternatives like modafinil.
Read clinical reviewModafinil is legal in the US only with a valid prescription for narcolepsy, shift-work sleep disorder, or sleep apnea. Learn the exact Schedule IV rules, how it compares to Adderall and Vyvanse, and what the evidence says about off-label cognitive use.
Read clinical reviewA physician-reviewed guide to lisdexamfetamine (Vyvanse) covering mechanism, approved uses, dosing, side effects, comparisons to Adderall and Ritalin, and how it fits into ADHD treatment in 2025.
Read clinical reviewLong COVID cognitive symptoms include brain fog, memory loss, attention problems, and slowed processing. Learn the mechanisms, diagnostics, and evidence-based treatments in this physician-reviewed guide.
Read clinical reviewA physician-reviewed guide to memantine (Namenda): how the NMDA antagonist works, approved doses, real clinical-trial outcomes, and how it fits alongside stimulants like modafinil, methylphenidate, and amphetamine salts.
Read clinical reviewA clinician-reviewed guide to methylphenidate (Ritalin, Concerta): mechanism, dosing schedules, side-effect profiles, head-to-head data vs. amphetamine salts, and when non-stimulant alternatives make sense.
Read clinical reviewA physician-reviewed comparison of methylphenidate (Ritalin, Concerta) and amphetamine (Adderall, Vyvanse) covering mechanism, efficacy, side effects, abuse potential, and how to choose between them.
Read clinical reviewA clinician-reviewed guide to mild cognitive impairment (MCI): how it differs from normal aging and dementia, what diagnostic criteria look like, which interventions show real evidence, and when to escalate care.
Read clinical reviewA physician-reviewed guide to modafinil (Provigil), covering FDA-approved uses, off-label cognitive applications, dosing, side effects, drug interactions, and head-to-head comparisons with armodafinil, methylphenidate, and amphetamines.
Read clinical reviewA physician-reviewed guide to modafinil standard dosing covering approved doses, titration schedules, timing, off-label cognitive use, and how to switch from other wakefulness agents.
Read clinical reviewModafinil and Adderall work through different mechanisms, carry different abuse risks, and suit different clinical situations. Here is how to choose between them based on evidence.
Read clinical reviewA clinician-reviewed guide to narcolepsy and excessive daytime sleepiness covering diagnostic criteria, FDA-approved medications, and what to expect from treatment.
Read clinical reviewPhenibut withdrawal can produce severe anxiety, insomnia, and psychosis-like symptoms lasting weeks. Learn the real timeline, risk factors, medical detox options, and what clinicians recommend for tapering safely.
Read clinical reviewA physician-reviewed guide to phenibut covering pharmacology, cognitive effects, abuse potential, withdrawal, and how it compares to prescription options like modafinil, armodafinil, methylphenidate, and amphetamine salts.
Read clinical reviewPost-concussion cognitive issues including brain fog, memory problems, and attention deficits can persist for weeks to months. Learn the neuroscience, diagnostic criteria, and evidence-based treatments for post-concussion syndrome.
Read clinical reviewA clinician-reviewed guide to ADHD medication safety during pregnancy, covering stimulants, non-stimulants, fetal risk data, dosing strategies, and postpartum planning for women with ADHD.
Read clinical reviewA clinician-reviewed comparison of the racetam nootropics (piracetam, aniracetam, oxiracetam) versus modafinil, armodafinil, methylphenidate, and amphetamine salts, covering mechanisms, evidence quality, dosing, and safety.
Read clinical reviewA physician-reviewed guide to rivastigmine (Exelon) covering FDA-approved indications, dosing, side effects, drug interactions, and head-to-head comparisons with modafinil, armodafinil, methylphenidate, and amphetamine salts.
Read clinical reviewA physician-reviewed guide to solriamfetol (Sunosi): mechanism, approved doses, clinical trial data, comparison to modafinil and amphetamines, and who qualifies for a prescription.
Read clinical reviewA physician-reviewed guide to stimulant cardiovascular risk covering arrhythmias, hypertension, sudden cardiac death, stimulant use disorder signs, and phenibut withdrawal. Includes dosing data, named trials, and clinical decision frameworks.
Read clinical reviewA clinician-reviewed guide to recognizing stimulant use disorder signs, understanding the cardiovascular dangers of chronic stimulant misuse, and what phenibut withdrawal actually looks like.
Read clinical reviewA physician-reviewed comparison of Strattera (atomoxetine) vs stimulant ADHD medications including Adderall, Vyvanse, Ritalin, and modafinil. Covers mechanism, efficacy data, side effects, dosing, and who each drug fits best.
Read clinical reviewLearn when and how to switch ADHD medications safely, including stimulant-to-stimulant, stimulant-to-non-stimulant, and modafinil transitions, with dose titration schedules and red-flag signs.
Read clinical review